Immune function and infections in older adults
Part of Infections clinical trials.
This study looks at how the immune system works in older adults and how it relates to infections. It aims to develop better ways to prevent and manage infectious diseases in people over 60.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years old or older.
- You should be generally healthy, without severe organ failure (like heart, liver, or kidney failure) or significant malnutrition.
- If you have an infection, a doctor must have confirmed it. If not, you can join as a healthy volunteer.
- You need to be able to communicate and follow the study procedures.
- You must provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
This study looks at how the immune system ages in people over 60 with inflammatory bowel disease (IBD) and how well newer treatments work for them. It aims to find out if immune aging affects treatment success.
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
This study tests whether a regular aerobic exercise program can help keep your immune system strong as you age. If you live in a care home, joining this program might improve your body's ability to fight off illness.
This trial tests whether a combination of a supplement and moderate exercise can help keep your immune system strong and healthy as you age. It is for older adults who are independent and generally healthy.
This study looks at how certain immune system markers, called inflammasomes, relate to frailty (physical weakness and vulnerability) in older adults who are candidates for kidney transplantation. The goal is to better understand these markers, which might help improve care for older transplant patients in the future.
Hear when a new Immunosenescence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.